Impact of hemostatic function assessed by Total Thrombus-formation Analysis System (T-TAS01) on bleeding events during transcatheter aortic valve replacement

Impact of hemostatic function assessed by Total Thrombus-formation Analysis System (T-TAS01) on bleeding events during transcatheter aortic valve replacement - COFFEESHOPS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048783

Enrollment

200

Registered

2022-08-30

Start date

2022-08-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic stenosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with severe aortic stenosis.

Exclusion criteria

Exclusion criteria: Exclusion criteria were (1) cases in which antithrombotic therapy could not be introduced preoperatively, and (2) cases in which consent to participate in the study could not be obtained. The exclusion criteria for analysis were (1) TAVI cases requiring more than two valve implantations intraoperatively, (2) cases requiring unplanned coronary revascularization or open chest surgery intraoperatively, and (3) cases in which new atrial fibrillation developed during hospitalization.

Design outcomes

Primary

Measure	Time frame
PL-AUC10, AR-OT and AR-AUC30, perioperative and post-discharge bleeding events: degree of bleeding, presence and volume of blood transfusion, unanticipated withdrawal of antithrombotic therapy, vascular complications, perioperative and Post-discharge embolic events: myocardial infarction, stroke death, in-hospital death and post-discharge death.	—

Countries

Japan

Contacts

Public ContactTaiga Katayama

Teikyo university Internal medicine

taiga.k1202@gmail.com0339641211

Outcome results